Back to search
FDAFDA · Food and drugs·Recall number D-1313-2016

Atropine Sulfate 0.4mg/mL 2.5 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC # 45183-0867-71

Published July 20, 2016 · Recall initiated: April 20, 2016

Summary

FDA records drug Class II recall D-1313-2016, published July 20, 2016 and initiated April 20, 2016. Recalling firm: Pharmakon Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 400; Lot: All Sterile Compounded Products within Expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmakon Pharmaceuticals, Inc.
Distributor
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA
Lot
All Sterile Compounded Products within Expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate 0.4mg/mL 2.5 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC # 45183-0867-71 recalled?

Yes. FDA published recall D-1313-2016 on July 20, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release